Hoogeveen, R. M., Verweij, S. L., Kaiser, Y., Kroon, J., Verberne, H. J., Vogt, L., . . . Stroes, E. S. G. (2021). Atorvastatin treatment does not abolish inflammatory mediated cardiovascular risk in subjects with chronic kidney disease. Nature Portfolio.
Cita Chicago Style (17a ed.)Hoogeveen, Renate M., Simone L. Verweij, Yannick Kaiser, Jeffrey Kroon, Hein J. Verberne, Liffert Vogt, Sophie J. Bernelot Moens, y Erik S. G. Stroes. Atorvastatin Treatment Does Not Abolish Inflammatory Mediated Cardiovascular Risk in Subjects with Chronic Kidney Disease. Nature Portfolio, 2021.
Cita MLA (8a ed.)Hoogeveen, Renate M., et al. Atorvastatin Treatment Does Not Abolish Inflammatory Mediated Cardiovascular Risk in Subjects with Chronic Kidney Disease. Nature Portfolio, 2021.